pCAG-VSVG Citations (6)
Originally described in: Genetic Neuroengineering Group PlasmidsUnpublished
Articles Citing pCAG-VSVG
| Articles |
|---|
| Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. Li M, Du J, Liu W, Li Z, Lv F, Hu C, Dai Y, Zhang X, Zhang Z, Liu G, Pan Q, Yu Y, Wang X, Zhu P, Tan X, Garber PA, Zhou X. ISME J. 2023 Apr;17(4):549-560. doi: 10.1038/s41396-023-01368-2. Epub 2023 Jan 23. PubMed |
| Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines. Licht-Murava A, Meadows SM, Palaguachi F, Song SC, Jackvony S, Bram Y, Zhou C, Schwartz RE, Froemke RC, Orr AL, Orr AG. Sci Adv. 2023 Apr 21;9(16):eade1282. doi: 10.1126/sciadv.ade1282. Epub 2023 Apr 19. PubMed |
| Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance. Perales-Linares R, Leli NM, Mohei H, Beghi S, Rivera OD, Kostopoulos N, Giglio A, George SS, Uribe-Herranz M, Costabile F, Pierini S, Pustylnikov S, Skoufos G, Barash Y, Hatzigeorgiou AG, Koumenis C, Maity A, Lotze MT, Facciabene A. Cancer Res. 2023 Nov 1;83(21):3562-3576. doi: 10.1158/0008-5472.CAN-22-2499. PubMed |
| Integrated proteomics reveals autophagy landscape and an autophagy receptor controlling PKA-RI complex homeostasis in neurons. Zhou X, Lee YK, Li X, Kim H, Sanchez-Priego C, Han X, Tan H, Zhou S, Fu Y, Purtell K, Wang Q, Holstein GR, Tang B, Peng J, Yang N, Yue Z. Nat Commun. 2024 Apr 10;15(1):3113. doi: 10.1038/s41467-024-47440-z. PubMed |
| The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect. Klemm N, Schimmer RR, Konrad NK, Thelen F, Fullin J, Topcu E, Koch C, Treacy M, Leventhal MJ, Buhler MM, Lysenko V, Theocharides APA, Kurppa KJ, Balabanov S, Baubec T, Krivtsov AV, Miller PG, Armstrong SA, Ebert BL, Manz MG, Nombela-Arrieta C, Boettcher S. Cancer Res. 2025 Jun 2;85(11):1978-1996. doi: 10.1158/0008-5472.CAN-24-1136. PubMed |
| Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapy. Zhang M, Gu Y, Shen F, Gong Y, Gu Z, Hua K, Zhou G, Ding J. J Ovarian Res. 2025 May 5;18(1):95. doi: 10.1186/s13048-025-01672-9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.